Objective
Driven by clinical applications and MNT and IST technology, SmartHEALTH will develop an open integrated architecture for new biodiagnostic systems to support European companies exploiting bioassays or new application concepts. Initial system has a disposable fluidic cartridge with a desktop basestation linking to the ambient eHealth environment - health cards, patient data, online services. This concept will be miniaturised and cost engineered into a portable and consumer product. It will perform multianalyate sensing and interpretation, for nucleic acids, proteins and others and will handle multiple biological sample types.
Results will be interpreted and presented using bioinformatics. Systems will be healthcare user identity and ambient environment aware, respecting confidentiality and information access rights. The IP will enable enhanced medical diagnosis, leading to earlier and more precise results contributing to an increased quality of life as well as increasing the competitiveness of the European IVD sector. The IP will include: selection of probes, sample preparation, fluid handling, concentration, filtering; sensors and transducers, (label free systems and rapid nucleic acid detection systems); surface modification/integration of nanoscale elements; system development - controllers, actuators, data processing, communications and integration with ambient intelligence, on-line information services; understanding of fit to healthcare, input to medical management - user factors, costs, approvals, regulations, ethics.
Clinical areas are in Cancer Diagnostics - breast cancer recurrence monitoring, cervical cancer case finding, colorectal cancer - diagnostic/theranostic/prognostics. Each application includes clinical validation and commercial exploitation partners. The consortium is a powerful set of 3 Universities, 9 Research Institutions, 10 SMEs, 4 larger Companies and 4 Clinical Groups covering all the relevant issues.
Fields of science
- natural sciencesbiological sciencesbiochemistrybiomoleculesnucleic acids
- social scienceseconomics and businessbusiness and managementcommercee-commerce
- medical and health sciencesclinical medicineoncologybreast cancer
- medical and health sciencesclinical medicineoncologycolorectal cancer
- medical and health sciencesclinical medicineoncologycervical cancer
Keywords
Call for proposal
Data not availableFunding Scheme
IP - Integrated ProjectCoordinator
NE1 7RU NEWCASTLE UPON TYNE
United Kingdom
See on map
Participants (30)
2007 NEUCHATEL
See on map
10117 BERLIN
See on map
GLASNEVIN, DUBLIN 9
See on map
76133 KARLSRUHE
See on map
80686 MUENCHEN
See on map
07743 JENA
See on map
41455 GOTEBORG
See on map
48170 ZAMUDIO
See on map
48150 SONDIKA
See on map
48903 CRUCES/BARAKALDO
See on map
20014 DONOSTIA - SAN SEBASTIAN
See on map
20500 ARRASATE - MONDRAGON
See on map
55129 MAINZ
See on map
3001 LEUVEN
See on map
TW1 4JX TWICKENHAM MIDDLESEX
See on map
07745 JENA
See on map
3179 SCORESBY, VICTORIA
See on map
414 58 GOTEBORG
See on map
2628 VK DELFT
See on map
11020 ARNAD
See on map
01006 VITORIA - GASTEIZ
See on map
7465 TRONDHEIM
See on map
413 46 GOTEBORG
See on map
20123 MILANO
See on map
2007 NEUCHATEL
See on map
UNDEFINED
See on map
43003 TARRAGONA
See on map
TRENTO
See on map
80331 MUENCHEN
See on map
SN2 2QW SWINDON, WILTSHIRESWINDON WILTSHIRE
See on map